logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Sangamo BioSciences (SGMO) Hits 10-Year High on Deal with Biogen (BIIB)

By  +Follow January 9, 2014 12:51PM
Share:
Tickers Mentioned:

Shares in Richmond, CA-based clinical stage biopharmaceutical company Sangamo BioSciences (SGMO) spiked nearly 35 percent on Thursday on news of a partnership with Biogen Idec (BIIB) to develop treatments for disorders affecting hemoglobin.

Biogen made an initial payment of $20 million to Sangamo as part of a deal that will total some $300 million in funding as well as double-digit royalties for Sangamo.

Lucrative Deal Drives SGMO to 10-Year High

On the whole, the size and generosity of the deal appear to make this a major win for Sangamo.

"The deal terms are very lucrative for a pre-clinical platform,” said Wedbush analyst Liana Moussatos. “So I think Biogen must have been impressed with the pre-clinical data that Sangamo presented last month."

The spike drove Sangamo to close to $19 a share, its highest level since 2001. It also passed the previous five-year high the company reached when shares were touching $18.50 in 2007.

Hemoglobin Disorders Affect Blood’s Ability to Carry Oxygen

Hemoglobin is the component of blood that carries oxygen, and disorders affecting hemoglobin include sickle cell disease and beta thalassemia. Both are very serious conditions and included in the category known as hemoglobinopathies.

Sangamo has developed technology to replace defective genes in patients with a corrective one, and Biogen appears to believe that this method has the potential to create one treatment for both diseases.

Sangamo will be responsible for research and development of the treatment up to the initial proof-of-concept trial.

SGMO Product Pipeline Could Have Potential

While Thursday’s announced partnership clearly took Sangamo to new levels, boosting the company’s market cap from $843.57 million to almost $1.15 billion in a matter of hours, the company has several treatments in its product pipeline that could also be major developments.

Most notable is lead therapy SB-728, which has the potential to develop into a functional cure for HIV/AIDS. The treatment would function by drawing immune cells, removing the protein pathway used by HIV to infect them, and then returning them to the patient’s bloodstream.

Sangamo’s promise appears to have won over investors, with the stock jumping over 130 percent despite the company failing to turn a profit and garnering revenues under $25 million in each of the last five years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for SGMO
BreakingStocksNews
1 Mar 15 19:46:06
$SGMO: Share Price of Sangamo BioSciences, Inc. Drops by -0.74%: http://t.co/0Gdz9ftg4u
Russell Barbour
1 Mar 15 09:42:05
***REVIEW*** Super Alerts stock picking service: http://t.co/1CdMJBAtCs $SGMO $ZU $LJPC $EFA $FRGI $ASX $CINF $BBEP $WB $BND
US Banking News
1 Mar 15 04:57:38
Sangamo Biosciences Receives Outperform Rating from Wedbush $SGMO http://t.co/cEP4MW90r8
US Consumer News
1 Mar 15 04:31:04
Sangamo Biosciences's outperform rating reiterated at Wedbush. $30.00 PT. http://t.co/90F43nSCHk $SGMO #SGMO
Media Sentiment
1 Mar 15 04:24:50
$SGMO received a new alert. Find out why at http://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt #NYSE #NASDAQ #markets 3
Analyst Ratings
1 Mar 15 04:23:18
Sangamo Biosciences's outperform rating reiterated at Wedbush. $30.00 PT. http://t.co/vLsO6IQgHO $SGMO #SGMO
Russell Barbour
1 Mar 15 01:29:34
***REVIEW*** Super Alerts stock picking service: http://t.co/1CdMJBAtCs $SGMO $ZU $LJPC $EFA $FRGI $ASX $CINF $BBEP $WB $BND
Russell Barbour
28 Feb 15 12:00:27
Really want to make money trading next year? try Super_trades alerts! http://t.co/1CdMJBAtCs $SGMO $ZU $LJPC $EFA $FRGI $ASX
Phil Martin
28 Feb 15 09:35:58
$SGMO http://t.co/lJbXnh75ab
Russell Barbour
27 Feb 15 20:01:12
***REVIEW*** Super Alerts stock picking service: http://t.co/1CdMJBAtCs $SGMO $ZU $LJPC $EFA $FRGI $ASX $CINF $BBEP $WB $BND
Syed Waqas Nabi
27 Feb 15 13:00:35
A bullish Big MAC (Bullish) has occurred at 3:15 PM Feb 27 at $16.93 on Sangamo BioSciences Inc (SGMO) $SGMO
Russell Barbour
27 Feb 15 12:17:28
Really want to make money trading next year? try Super_trades alerts! http://t.co/1CdMJBAtCs $SGMO $ZU $LJPC $EFA $FRGI $ASX
Healthcare Stocks
27 Feb 15 06:59:14
Biogen's hemophilia B med successful in Phase 3 trial in children http://t.co/CsMqEiQKfe $BIIB $BAX $OPK $SGMO
SA Breaking News
27 Feb 15 06:59:13
Biogen's hemophilia B med successful in Phase 3 trial in children http://t.co/QI47HPd3t2 $BIIB $BAX $OPK $SGMO
RNA_Biotech
27 Feb 15 03:51:18
$SGMO New Clinical Data at CROI 2015 From Trial of #ZFP Therapeutic Designed to Provide Functional Control of HIV http://t.co/6hSpeT3YTI
Joe
26 Feb 15 21:15:38
Big Insider buying recently in $sgmo $adxs & $idra: http://t.co/CdlJv1ZYJS
Russell Barbour
26 Feb 15 18:59:36
Really want to make money trading next year? try Super_trades alerts! http://t.co/1CdMJBAtCs $SGMO $ZU $LJPC $EFA $FRGI $ASX
ARK Genome
26 Feb 15 13:35:01
$SGMO's new data shows that their hope for a "functional cure" for #HIV may be possible: http://t.co/ueZ6O1lGi9
Investors Hangout
26 Feb 15 12:21:40
clayton: SGMO 16.96 Sangamo Biosciences $SGMO added to my http://t.co/tPpmOp0gq4
Investors Hangout
26 Feb 15 12:21:40
clayton: SGMO 16.96 Sangamo Biosciences $SGMO stock added http://t.co/8RcWVKWdUo
Investors Hangout
26 Feb 15 12:21:36
clayton: SGMO 16.96 Sangamo Biosciences $SGMO added to my http://t.co/LCZXbnpVSj
Investors Hangout
26 Feb 15 12:21:36
clayton: SGMO 16.96 Sangamo Biosciences $SGMO stock added http://t.co/tpvZ499PJL
Langan Stocks
26 Feb 15 12:19:06
clayton: SGMO 16.96 Sangamo Biosciences $SGMO added to my http://t.co/Itms1mdWYb
clayton
26 Feb 15 12:15:27
SGMO 16.96 Sangamo Biosciences $SGMO added to my watch list. Right now with SGMO I am watching the last price http://t.co/qiusFRAqRM
clayton
26 Feb 15 12:15:05
$SGMO SGMO 16.96 Sangamo Biosciences $SGMO stock added to my watch list. Right now with SGMO I am watching the last http://t.co/CbHTD76C69
Market Int Center
26 Feb 15 11:03:18
Sangamo Biosciences $SGMO Trading Near $17.59 Resistance Level ( http://t.co/0QEZTuvqWO )
Daily Contracts
26 Feb 15 10:15:00
Real-Time feed of company contracts, original agreements and executive updates from $SGMO http://t.co/QTLYvfCV5H
Adam Singer
26 Feb 15 08:23:15
@AustinJamison1 yeah $SGMO was a hot call, I found that one independently. Flipped from 12s :-)
Austin Jamison Kurtz
26 Feb 15 08:14:43
@AdamSinger Hi Adam, U liked my post on $SGMO Portfolio up 37% since end 'of 13. $ACAD $FB $JUNO $MSFT $OAS $TWTR $VUZI $YHOO Plz follow me
Briefing.com
26 Feb 15 06:12:05
$SGMO: Sangamo Biosci at CROI 2015 presents new clinical data from ZFP Therapeutic trial http://t.co/caoGbNWCXY
Penny Stock Secret
26 Feb 15 05:13:59
This Guy Turned $100 Into Over $10,000 In Just 30 Days!!! http://t.co/NovWYe2RAx ... $IMDZ $SGMO $BOTJ
4-traders.com
26 Feb 15 04:36:06
#Sangamo BioSciences : Presents New Clinical Data at CROI 2015 From Trial of Z... http://t.co/CAyHK2tqnD $SGMO
biotech 2050
26 Feb 15 04:33:19
RT @BlinkX90: $SGMO New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to Provide Functional Control of HIV http://t.co…
Joshua B
26 Feb 15 04:11:23
RT @BlinkX90: $SGMO New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to Provide Functional Control of HIV http://t.co…
Blink
26 Feb 15 04:10:46
$SGMO New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to Provide Functional Control of HIV http://t.co/rqDDEAqCnJ
Breaking News
26 Feb 15 04:05:39
$SGMO Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed... http://t.co/1yQYCc55Gr
$Stocknewsalerts
26 Feb 15 04:04:13
$SGMO Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic(R) Designed t From our Stock News Alerts App
StockNews
26 Feb 15 04:03:39
$SGMO - Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to http://t.co/PP9TJmt03a
Stocks News&Markets
26 Feb 15 04:03:35
$SGMO - Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to http://t.co/dSn2yjrlhS
BreakingStocksNews
26 Feb 15 02:56:03
$SGMO: Analyst Rating Update on Sangamo Biosciences, Inc.: http://t.co/uXZG0hOGs8
biotech 2050
26 Feb 15 02:14:58
$SGMO Sangamo Biosciences pipeline http://t.co/dy3qVDS152
Russell Barbour
25 Feb 15 21:22:12
Really want to make money trading next year? try Super_trades alerts! http://t.co/1CdMJBAtCs $SGMO $ZU $LJPC $EFA $FRGI $ASX
biotech 2050
25 Feb 15 21:17:13
RT @dougheuringaria: @dougheuringaria $SGMO http://t.co/rktzBOOrrR
Russell Barbour
25 Feb 15 15:38:56
Really want to make money trading next year? try Super_trades alerts! http://t.co/1CdMJBS512 $SGMO $ZU $LJPC $EFA $FRGI $ASX
Caliann Lum
25 Feb 15 14:39:05
@optionmonster Have $SGMO for a while. Not as hot as early $VRTX story but amazing technology. Following $RARE Investigator a real hotshot.
StockNews
25 Feb 15 13:45:09
$SGMO - Annual Report (10-k) http://t.co/gOwLclJ64Y
Stocks News&Markets
25 Feb 15 13:44:31
$SGMO - Annual Report (10-k) http://t.co/SMnY0k7TYh
Instrumental Data
25 Feb 15 13:38:43
SANGAMO BIOSCIENCES INC $SGMO 10-K now available
Breaking News
25 Feb 15 13:35:02
$SGMO: New SEC Filing for SGMO: Form 10-K (No. 0001564590-15-000950): http://t.co/QQjvF67wuJ
Company SEC Filings
25 Feb 15 13:34:20
NEW SEC Filing for $SGMO filed a moment ago: http://t.co/RZDXWP9U6q http://t.co/jS7hdyVjJH
				
				
By  +Follow January 9, 2014 12:51PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.